Financial Daily from THE HINDU group of publications
Thursday, Jan 30, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Alliances & Joint Ventures


Reliance Life in pact with Thyrocare

Our Bureau

MUMBAI, Jan. 29

RELIANCE Life Sciences has tied up with the Thane-based thyroid-testing laboratory Thyrocare Technologies Ltd to offer DNA-based genetic testing services.

According to a press release, Thyrocare will procure blood samples from its network of 340 franchisees and provide air-cargo logistics. In turn, Reliance Life Sciences will provide testing services and will make the reports available through an integrated Web-based reporting system.

Article E-Mail :: Comment :: Syndication

Stories in this Section
PwC for I-T guidance on valuation methods


BILT approves Janpath plan
`ICAI yet to respond to audit panel suggestions'
Export orders push L&T net up 47 pc
Timex posts 40% sales growth
GAIL net up 17% on better throughput
Nirma Q3 net up at Rs 64 cr
Gulf Oil net quadruples on higher sales
Apollo Hospitals Q3 PAT up 11.5%
MRF Q1 net doubles
M&M net higher at Rs 30 cr in Q3
Price fall hits India Cements net
Grand Group income up at Rs 21.2 cr
Zydus Cadila net rises 18 pc in Q3
Chettinad Cement posts higher loss
Madras Cements sales income down, Q3 PAT up 22%
IOC records Rs 777-crore net profit
Blue Star Q3 net up at Rs 3.4 cr
L&T discusses CDC plan; Grasim proposal tabled
Cadila-German Remedies merger swap fixed at 7:4
Asian Paints plans to set up unit at Pondy
Reliance Life in pact with Thyrocare
`Innovation will drive HLL growth'
Foods business proves an unhealthy diet
HLL fourth quarter exports up 13 pc
To deny voting rights to Indian shareholders — Coke knocks at FIPB doors
Vinod Rao appointed CFO of PepsiCo India


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line